Soung J, Tiu L, Veverka K, Hong C-H. Patient Preference for Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam or Topical Suspension vs. Latest Topical Treatment in the PSO-INSIGHTFUL Study. J of Skin [Internet]. 2018Feb.23 [cited 2024Jul.22];2(S1):S10. Available from: https://jofskin.org/index.php/skin/article/view/279